The National Science Foundation SBIR/STTR Program supports small enterprises carrying out innovative R&D in 10 wide topic areas, including...
The second due dates are in Summer of 2016.
You can communicate with system Director Ruth Shuman (email@example.com) to evaluate if a project satisfies this system's intellectual merit and commercial effect requirements. E-mail a 1-2 web page manager summary discussing listed here areas of the project: 1) the company and staff 2) the marketplace opportunity, price proposition, and customers 3) the technology/innovation 4) the competition. Please be aware that responsiveness will probably be limited when you look at the 14 days prior to the solicitation deadline.
BT1. Agricultural and Food Safety Biotechnology
Brand-new techniques for satisfying the entire world's future health requirements. For Agricultural Biotechnology, target places for improvement can include (but they are not restricted to) drought threshold, enhanced nutritional value, improved disease resistance, and greater yield. Proposers should use biotechnology within their approach, and may give consideration to technologies that enhance biodiversity, produce less carbon-dioxide, and employ less water and fertilizer. For Food Safety, this may include dealing with, preparation, and storage space of food with techniques that counter foodborne disease, and origins of food including the practices associated with food monitoring, hygiene, ingredients, and certification systems.
Biosensors tend to be sensors which contain a biologically-based sensing factor. Proposed projects might integrate (but are not limited to) real-time detectors, microbial component-based sensors, detectors for monitoring fluxes of metabolites, nanobiotechnology-based sensors, biomedical sensors, and micro- or nanofluidic-based sensors. Application areas of interest can sometimes include (but are not restricted to) toxicity evaluating, food security, drug analysis, ecological monitoring, and bio-prospecting. Other types of detectors should make reference to the EI topic.
BT3. Lifestyle Sciences Analysis Tools
Establishing novel technologies that'll advance systematic study over the biological range. This could integrate allowing technologies for medicine breakthrough (high-throughput evaluating assays and platforms, and high-content testing assays and systems; novel high-content assessment technologies based on characterization of actual properties of cells tend to be of high interest). Proposals should concentrate primarily on the growth of innovative consumables, processes, and services in which there's significant marketplace possibility.
Additionally, our company is thinking about new tools for mind analysis, specially those who help with dealing with fundamental neurobiological questions regarding mind purpose, laying the groundwork for advancing treatments for nervous system problems or terrible brain injury, and for producing brain-inspired "wise" technologies to generally meet future societal requirements.
The development of technology for novel or enhanced instrumentation mainly for biological research applications. Besides, this could integrate low-cost instruments for technology and manufacturing that are aimed at pupils or other individuals in doing work in low resource options.
BT5. Synthetic Biology and Metabolic Engineering
Utilizing synthetic biology to engineer novel biologically-based (or empowered) features that don't occur in the wild. Recommended tasks may include producing brand-new manufacturing capacity by designing microorganisms, plants, and cell-free methods for the creation of novel chemicals and biomolecules. Programs can sometimes include (but they are not limited to) health-care items, food components, chemicals, and other biomaterials particularly enzymes and bio-based polymers.
BT6. Fermentation and Cell Customs Technologies
Recommended tasks might include (but are not restricted to) book or enhanced microbial fermentation or mammalian and plant mobile culture technologies, bioreactors, processes, scale-up, development of expression platforms, and purification. This could integrate technology development for pilot and large scale manufacturing of biopharmaceutical as well as other services and products.